184 related articles for article (PubMed ID: 30987780)
1. New analogs of SYA013 as sigma-2 ligands with anticancer activity.
Asong G; Zhu XY; Bricker B; Andey T; Amissah F; Lamango N; Ablordeppey SY
Bioorg Med Chem; 2019 Jun; 27(12):2629-2636. PubMed ID: 30987780
[TBL] [Abstract][Full Text] [Related]
2. SYA 013 analogs as moderately selective sigma-2 (σ
Al-Ghanim L; Zhu XY; Asong G; Ablordeppey SY
Bioorg Med Chem; 2019 Jun; 27(12):2421-2426. PubMed ID: 30737135
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors.
Zampieri D; Romano M; Fortuna S; Amata E; Dichiara M; Cosentino G; Marrazzo A; Mamolo MG
Molecules; 2024 Jun; 29(11):. PubMed ID: 38893570
[TBL] [Abstract][Full Text] [Related]
4. An Evaluation of the Anticancer Properties of SYA014, a Homopiperazine-Oxime Analog of Haloperidol in Triple Negative Breast Cancer Cells.
Asong GM; Voshavar C; Amissah F; Bricker B; Lamango NS; Ablordeppey SY
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551533
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.
Peprah K; Zhu XY; Eyunni SV; Etukala JR; Setola V; Roth BL; Ablordeppey SY
Bioorg Med Chem; 2012 Mar; 20(5):1671-8. PubMed ID: 22336245
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
Liu CZ; Mottinelli M; Nicholson HE; McVeigh BM; Wong NK; McCurdy CR; Bowen WD
Eur J Pharmacol; 2021 Sep; 906():174263. PubMed ID: 34144027
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.
Sun YT; Wang GF; Yang YQ; Jin F; Wang Y; Xie XY; Mach RH; Huang YS
Eur J Med Chem; 2018 Mar; 147():227-237. PubMed ID: 29438891
[TBL] [Abstract][Full Text] [Related]
8. A Mechanistic Investigation on the Anticancer Properties of SYA013, a Homopiperazine Analogue of Haloperidol with Activity against Triple Negative Breast Cancer Cells.
Asong GM; Amissah F; Voshavar C; Nkembo AT; Ntantie E; Lamango NS; Ablordeppey SY
ACS Omega; 2020 Dec; 5(51):32907-32918. PubMed ID: 33403252
[TBL] [Abstract][Full Text] [Related]
9. Bicycloheptylamine-Doxorubicin Conjugate: Synthesis and Anticancer Activities in σ2 Receptor-Expressing Cell Lines.
Alamri MA; Ates-Alagoz Z; Adejare A
Med Chem; 2020; 16(2):192-201. PubMed ID: 30827254
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
Yarim M; Koksal M; Schepmann D; Wünsch B
Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
[TBL] [Abstract][Full Text] [Related]
11. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells.
Marrazzo A; Fiorito J; Zappalà L; Prezzavento O; Ronsisvalle S; Pasquinucci L; Scoto GM; Bernardini R; Ronsisvalle G
Eur J Med Chem; 2011 Jan; 46(1):433-8. PubMed ID: 21055848
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CM572, a Selective Irreversible Partial Agonist of the Sigma-2 Receptor with Antitumor Activity.
Nicholson H; Comeau A; Mesangeau C; McCurdy CR; Bowen WD
J Pharmacol Exp Ther; 2015 Aug; 354(2):203-12. PubMed ID: 26034081
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, σ₁, σ₂-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes.
Riganas S; Papanastasiou I; Foscolos GB; Tsotinis A; Bourguignon JJ; Serin G; Mirjolet JF; Dimas K; Kourafalos VN; Eleutheriades A; Moutsos VI; Khan H; Georgakopoulou S; Zaniou A; Prassa M; Theodoropoulou M; Pondiki S; Vamvakides A
Bioorg Med Chem; 2012 May; 20(10):3323-31. PubMed ID: 22512908
[TBL] [Abstract][Full Text] [Related]
15. New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents.
Chu W; Xu J; Zhou D; Zhang F; Jones LA; Wheeler KT; Mach RH
Bioorg Med Chem; 2009 Feb; 17(3):1222-31. PubMed ID: 19119012
[TBL] [Abstract][Full Text] [Related]
16. An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones.
Lee IT; Chen S; Schetz JA
Eur J Pharmacol; 2008 Jan; 578(2-3):123-36. PubMed ID: 17961544
[TBL] [Abstract][Full Text] [Related]
17. 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity.
Berardi F; Ferorelli S; Abate C; Colabufo NA; Contino M; Perrone R; Tortorella V
J Med Chem; 2004 Apr; 47(9):2308-17. PubMed ID: 15084129
[TBL] [Abstract][Full Text] [Related]
18. Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.
Pati ML; Hornick JR; Niso M; Berardi F; Spitzer D; Abate C; Hawkins W
BMC Cancer; 2017 Jan; 17(1):51. PubMed ID: 28086830
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents.
Dichiara M; Amata E; Rescifina A; Prezzavento O; Floresta G; Parenti C; Pittalà V; Marrazzo A
Future Med Chem; 2017 Oct; 9(15):1749-1764. PubMed ID: 28869398
[TBL] [Abstract][Full Text] [Related]
20. Molecular hybridization of 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity.
Banister SD; Moussa IA; Jorgensen WT; Chua SW; Kassiou M
Bioorg Med Chem Lett; 2011 Jun; 21(12):3622-6. PubMed ID: 21555222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
